CGIH19111 / S1815 / Aram HezelResearch Question:
How well does gemcitabine hydrochloride and cisplatin - given with or without nab-paclitaxel
- work in treating patients with newly diagnosed biliary tract cancers?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
This phase III trial studies how well gemcitabine hydrochloride and cisplatin given
with or without nab-paclitaxel work in treating patients with newly diagnosed biliary
tract cancers that have spread to other places in the body. Drugs used in chemotherapy,
such as gemcitabine hydrochloride, cisplatin, and nab-paclitaxel, work in different
ways to stop the growth of tumor cells, either by killing the cells, by stopping them
from dividing, or by stopping them from spreading. It is not known if giving gemcitabine
hydrochloride and cisplatin with or without nab-paclitaxel may work better at treating
biliary tract cancers.
Study Reference #: CGIH19111
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Tina Bowdish
Phone: +1 585-275-9475
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search